Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 33465
Event :Allogeneic Cell Therapies Summit Europe

Dates :Tuesday January 18th, 2022 - Thursday January 20th, 2022

Location :Amba Marble Arch (Guoman)
Bryanston Street
W1H 7EH Greater London, United Kingdom

Type :Conference & Seminar - International audience

Accreditation :--


Further information


Address Key European Regulatory Challenges and Cutting Edge Platform Design to Advance Allogeneic Approaches
Allogeneic therapies are fast becoming the holy grail for cell therapy as they boast the potential to reduce the cost of goods, improve accessibility, reduce turnaround times and have the ability to treat masses of patients. However, in Europe there are critical challenges limiting clinical advancement, with increased complexities with disharmonized European regulations where guidance varies across countries, and challenges in cross-country logistics when running multicentric trials.
The Allogeneic Cell Therapies Summit Europe is the only industry-focused forum dedicated to address the specific challenges facing European drug developers in order to advance your pipeline to clinical and commercial success.
Collaborate with European leaders from Cellectis, Celyad, GammaDelta Therapeutics, Medicines and Healthcare Products Regulatory Agency and more to benchmark best-in-class approaches to achieve optimal clinical set up and large scale manufacture for your off-the-shelf product. Ensure you have these important considerations planned early in development to overcome delays and critical push backs later in your clinical translation.
Join your community in London this January to take on this next frontier in cell therapy and leave with cutting-edge strategies to develop safe, effective and accessible cell therapies for patients in Europe.
This is your comprehensive guide to define your commercial path forward developing off-the-shelf products.
18-20 January, 2022
London, UK
Drug Developers (Earlybird rates & workshops available) GBP 2599.00
Academic (Earlybird rates & workshops available) GBP 2099.00
Service Providers (Earlybird rates & workshops available) GBP 2999.00
Speakers: Miguel Forte, CEO, Bone Therapeutics, André Choulika, CEO, Cellectis, Vicki Coutinho, VP of Regulatory Affairs & Quality, GammaDelta Therapeutics, Troels Jordansen, CEO, Glycostem Therapeutics, Kimberly Schluns, Senior Director, Research, Kite Pharma, John Johnston, Clinical Assessor, MHRA
Date and Time: Starts: Tue, Jan 18, 2022 ( 8:00 AM) and Ends: Thu, Jan 20, 2022 ( 6:00 PM)


Map and directions
Conference address :
Amba Marble Arch (Guoman)
Bryanston Street
W1H 7EH Greater London
United Kingdom
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama


Allogeneic Cell Therapies Summit Europe Medicine
allogeneic, allogeneicapproaches, allogeneictherapies
-- -- --


For more information on Allogeneic Cell Therapies Summit Europe, plsase contactr Hanson Wade

To obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama

Recommend this event